Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Testing is here to stay for at least next 3 years for travel industry for international borders as Vaccine will take time to service the whole population on the planet regardless of you have been vaccinated or not you will still need Covid test done before travels to confirm you are still covid free at that point in time of traveling as vaccines may not give you immunity for more then 6 to 8 months depending on Vaccine type
From ADVFN
still clearing sellers - L&G, Sneller, Sneller's charities noticed that the £912m tender was updated today to extend deadline to next Wednesday hTTps://bidstats.uk/tenders/2020/W46/738590726 wonder if that is to allow MHRA approval to be given (which means it's coming within a week
UK Rapid Test Consortium (UK RTC), was brought together by the government’s life sciences advisor John Bell and also includes Oxford University, Abingdon Health, BBI Solutions and CIGA Healthcare.
UK RTC’s focus was on developing the AbC-19 Rapid Test which uses only a drop of blood from a finger-prick and provides results within 20 minutes, eliminating the need for a lab. The idea behind it was to have a quick test that will make it possible for people with antibodies to move about freely without the need to close businesses and restrict travel. By October the government had signed a contract with the group worth £75 million for one million testing kits.
Is anybody else here questioning the cost of each test?
However, last week the British Medical Journal published an article questioning the accuracy of the test, arguing that while it is fairly reliable in cases when people show Covid symptoms, in asymptomatic cases one in five were wrongly diagnosed. The company responded with a press release today saying that the Department of Health and Social Care is satisfied with the performance of the test, as is the UK-RTC, and that it will continue to roll out the use of the product
Brokers have struggled to put a target price on Omega Diagnostics in recent months. What do you think the barriers are to this and do you think it will become viable to do so soon?
finnCap’s price target is under review given the difficulty in forecasting revenues from COVID-19 antibody and antigen tests with any degree of accuracy. When that changes then we would expect finnCap to consider a target price.
That said, they have made it clear that even without firm forecasts or a target price the valuation upside is considered substantial and they have provided a very helpful assessment of potential revenues and gross profits at different utilisation rates in their note from 22 June 2020.
Boris Johnson takes a coronavirus test despite having NO symptoms as Downing Street says it is 'trialling' rapid screening kits
BREAKING: No.10 says
@BorisJohnson
has tested negative for covid, using a rapid, lateral flow test.
But will still self-isolate for the full 14 days until next Thurs.
It depands on your risk appetite ODX is not for faint hearted I am invested here but risk reward is huge can go either way 40p or to £1.50 a share, so for newbie like yourself I suggest safer bets with max looking for 30% gain this is only my opinion not an Advice stocks to look into RPS, PURP JUST, BWNG, again its for mid to longterm hold to gain profits
Expecting the following news flow:
1 United States FDA approval for ABC-19
2 MHRA approval for ABC-19
3 Further Gov orders
4 WHO approval of Mologic Triple Antibody Test
5 Validation of Mologic Slavia Lateral Flow Antigen test
6 SyringeAstraZ Vaccine updates
7 International Orders beyond UK
Be Patient and remove the stop losses or get eaten by sharks
The Company is confident there is a significant opportunity to sell the ABC-19 antibody tests beyond the UK, due to product performance, and its link to the UK Government.
I wonder what sp will be come March 2021
The director general of the World Health Organization says vaccines alone will not be enough. Governments will have to use vaccines and tests together.
trading update will be 30th November, they're going to discuss current capacity and orders !!!
Government to spend £42bn on private testing contracts
The sum is equivalent to the UK’s annual defence budget and involves contracts awarded on behalf of Public Health England and the NHS
Ministers are poised to hand out up to £42bn of taxpayer cash to private contractors as part of a drive to massively expand testing in fight against Covid
On Daily Telegraph
Institutional Shorts Total of 2.91%
Blackrock 2.27% opened on 11th Aug
Wellington 0.64% updated on 5th Nov but they were 0.76% on 28th Oct , so they closed the part of the short position 0.12% on the announcement of capital raise RNS on 5th Nov
Institutional Shorts Total of 2.91%
Blackrock 2.27% opened on 11th Aug
Wellington 0.64% updated on 5th Nov but they were 0.76% on 28th Oct , so they closed the part of the short position 0.12% on the announcement of capital raise RNS on 5th nov
beechhurst
Very good explanation, also can you look at the RPS example below and see if we have a same scenario here in regards to fund raise to improve growth
Look at another example RPS group placing RNS on 3rd sep share price was 43p and placing price was 44p, they used the raise capital to survive covid situation and pay some debt and arranged revolving credit bank facility, today the share price was 57p no dilution.
https://www.lse.co.uk/rns/RPS/proposed-placing-subscription-banking-amendment-9j9hqiqydpa2qjj.html
MCPrice
True if it was 57p share price today, why buy placing shares 11/18 allocation at 57p when you can buy at 51.50p today, I would buy over 60p if I had to provided all 174,000,000 million are taken up by Alliance or shareholders and when we have moved to AIM in Jan if share was trading at 60p at that point, but I am fully loaded up here at 54.66p a share and don't intend to buy my allocation at 57p placing, I hold 140,889 shares, will add is goes below 40p